Skip to Content

What type of drug is Olumiant?

Answers (1)

Official Answer by 23 Aug 2018

Olumiant (baricitinib), from Eli Lilly, is a Janus kinase (JAK) inhibitor. JAK inhibitors are intracellular enzymes that work by interfering with cytokine signaling to influence cell processes of immune cell function and inflammation. Olumiant is used alone or in combination with methotrexate or other non-biologic DMARDs for the treatment of moderate-to-severe rheumatoid arthritis (RA) in patients with an inadequate response to tumor necrosis factor (TNF) inhibitors.

In clinical trials, Olumiant had a significant response rate in RA compared to placebo after 12 weeks of treatment (49% versus 27% response rate, respectively). According to Eli Lilly, the price of Olumiant will be 60% less than the leading tumor necrosis factor (TNF) inhibitor. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of drug is Motegrity?

Updated 16 days ago 1 answerFAQ by

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 13 days ago 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 13 days ago 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 12 days ago 1 answerFAQ by